News on Angiogenesis Technologies Incorporated from BioPortfolio.com http://www.BioPortfolio.com Consolidated Angiogenesis Technologies Incorporated news from BioPortfolio.com Wed, 10 Feb 2010 09:56:35 GMT en Stock Hunter Is Hot!! Sign Up Today!! GETA,GOVX,NPWZ,VHGI,RDBO,SHMNhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032004&HITNO=0&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032004&THISHREF=http://c.moreover.com/click/here.pl%3fz2534464898%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032004&HITNO=0&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032004&THISHREF=http://c.moreover.com/click/here.pl%3fz2534464898%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Wipro and Trend Micro Unite to Deliver Next-Generation Virtualization Security Solutions for Dynamic Datacentershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990373&HITNO=1&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990373&THISHREF=http://c.moreover.com/click/here.pl%3fz2513292283%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990373&HITNO=1&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990373&THISHREF=http://c.moreover.com/click/here.pl%3fz2513292283%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Allegheny Technologies inks deals worth $250Mhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3985949&HITNO=2&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3985949&THISHREF=http://c.moreover.com/click/here.pl%3fz2508881287%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3985949&HITNO=2&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3985949&THISHREF=http://c.moreover.com/click/here.pl%3fz2508881287%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch & Development: Teledyne Technologies Announces Fourth Quarter and Full Year 2009 Earnings Webcast Detailshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3925630&HITNO=3&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3925630&THISHREF=http://c.moreover.com/click/here.pl%3fz2477784140%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3925630&HITNO=3&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3925630&THISHREF=http://c.moreover.com/click/here.pl%3fz2477784140%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: TimelessWealth.net: FDA related News Watch: BioDelivery Sciences International, Inc. (Nasdaq: BDSI), Vical Inchttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3898617&HITNO=4&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3898617&THISHREF=http://c.moreover.com/click/here.pl%3fz2462924287%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3898617&HITNO=4&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3898617&THISHREF=http://c.moreover.com/click/here.pl%3fz2462924287%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: FDA Approves Phase 3 Study Protocol for Angiogenesis Agenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3898576&HITNO=5&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3898576&THISHREF=http://c.moreover.com/click/here.pl%3fz2462910584%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3898576&HITNO=5&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3898576&THISHREF=http://c.moreover.com/click/here.pl%3fz2462910584%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiotechnology Healthcare: Breaking News!! AMCG 'Amico Games Corp. Anticipates Substantial Growth in 2010 and 2011' : Sign Up For Our Alehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3904117&HITNO=6&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3904117&THISHREF=http://c.moreover.com/click/here.pl%3fz2465536218%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3904117&HITNO=6&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3904117&THISHREF=http://c.moreover.com/click/here.pl%3fz2465536218%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Hot Stock to Watch: Wound Management Technologies ' January 13, 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3904114&HITNO=7&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3904114&THISHREF=http://c.moreover.com/click/here.pl%3fz2465535017%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3904114&HITNO=7&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3904114&THISHREF=http://c.moreover.com/click/here.pl%3fz2465535017%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: TimelessWealth, Inc.: TimelessWealth.net: FDA related News Watch: BioDelivery Sciences International, Inc. (Nahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3895423&HITNO=8&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3895423&THISHREF=http://c.moreover.com/click/here.pl%3fz2461382814%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3895423&HITNO=8&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3895423&THISHREF=http://c.moreover.com/click/here.pl%3fz2461382814%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRBC Dain Rauscher: Vical Licensee AnGes MG Reaches Agreement With FDA For Phase 3 Trial of Collategene(TM) Angiogenesis Producthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3896632&HITNO=9&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3896632&THISHREF=http://c.moreover.com/click/here.pl%3fz2461852784%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3896632&HITNO=9&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3896632&THISHREF=http://c.moreover.com/click/here.pl%3fz2461852784%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Vical Licensee AnGes MG Reaches Agreement With FDA For Phase 3 Trial of Collategene(TM) Angiogenesis Producthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3893224&HITNO=10&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3893224&THISHREF=http://c.moreover.com/click/here.pl%3fz2460526087%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3893224&HITNO=10&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Angiogenesis%20Technologies%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3893224&THISHREF=http://c.moreover.com/click/here.pl%3fz2460526087%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: